KapposLBatesDEdanG. Natalizumab treatment for multiple sclerosis: Updated recommendations for patient selection and monitoring. Lancet Neurol2011; 10: 745–758.
2.
PlavinaTSubramanyamMBloomgrenG. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol2014; 76: 802–812.
3.
DahlhausSHoepnerRChanA. Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients. J Neurol Neurosurg Psychiatry2013; 84: 1068–1074.
PitarokoiliKHellwigKLukasCGoldR. Successful pregnancy after natalizumabassociated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis. Mult Scler2017; 23: 483–486.
6.
McNamaraJFPatersonDLAllworthA. Re-activation of varicella zoster virus associated with anterior spinal cord stroke in pregnancy. Infect Dis2016; 48: 705–707.
7.
KalvatchevZSlavovSShterevaM. Reactivation of Polyomavirus hominis 1 (BKV) during pregnancy and the risk of mother-to-child transmission. J Clin Virol2008; 43: 328–329.
8.
CrossleyKMAgnihotriSChagantiJ. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol2016; 22: 541–545.
9.
Sanchez-QuintanaABrena-AtienzaJMarrero-SantosC. Late relapse of progressive multifocal leucoencephalopathy postallogenic transplant in a young patient with CLL. BMJ Case Rep. Epub ahead of print 5August2013. DOI: 10.1136/bcr-2013-200213.
